Clinical Trial Update: Adaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T) [NA]

View source ↗

Summary

Clinical trial update on adaptive bridging radiotherapy for relapsed/refractory B-cell lymphomas prior to CAR-T therapy; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Cancer
• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• High-grade B-cell Lymphoma
• Lymphoma
• Mantle Cell Lymphoma
• Mediastinal Large B-cell Lymphoma

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Lymphoma, B-Cell, Relapsed Cancer | NA | Status: COMPLETED